Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
NOVARTIS AG et al v. ACCORD HEALTHCARE, INC. USA et al
Case Number:
1:13-cv-01013
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 12, 2013
Novartis Settles Patent Suit Over Organ Transplant Drug
Novartis AG has reached a tentative settlement of its patent infringement suit over Accord Healthcare Inc. USA's pursuit of government approval for a generic form of the drug Myfortic, which prevents patients from rejecting transplanted organs, according to a joint motion filed Thursday in D.C. federal court.
-
July 03, 2013
Novartis Sues Accord Over Kidney Transplant Drug Patents
Novartis AG hit Accord Healthcare Inc. USA with a patent infringement lawsuit Wednesday in District of Columbia federal court, alleging that Accord's attempt to create a generic form of Myfortic, a medication that prevents the human body from rejecting an organ transplant, infringes its patents.